Columbia, Missouri 65212

  • Anemia in Pregnancy


The investigators will randomize women diagnosed with anemia in the mid-trimester of pregnancy to once or twice daily iron supplementation

Study summary:

Women defined as having iron deficiency anemia based on a low hemoglobin as defined by the American College of Obstetrics and Gynecology and a low serum ferritin, in the absence of hemoglobinopathy, will be randomized to ferrous sulfate 325mg PO daily or PO twice daily.


Inclusion Criteria: - Singleton gestation - Iron deficiency anemia as defined by a Hgb of less than 11mg/dL in the first and 3rd trimester and 10.5mg/dL in the 2nd trimester and a serum ferritin of less than 15ug/mL. - In accordance with American College of Obstetricians and Gynecologists (ACOG) guidelines, the Hgb cutoff will be reduced by 0.8mg/dL in African American women. - In accordance with the standard of care, African American women and those with a mean corpuscular volume (MCV) on their routine screening complete blood count (CBC) of less than 70 will require a hemoglobin electrophoresis to exclude hemoglobinopathy prior to enrollment. Exclusion Criteria: - Multiple gestation - Maternal hemoglobinopathy or hemochromatosis, - Irritable bowel disease or irritable bowel syndrome - History of bariatric surgery or extensive bowel surgery - Individuals already receiving iron supplementation aside from prenatal vitamins.



Primary Contact:

Daniel Jackson
Phone: 5734996041

Backup Contact:

Elizabeth J Mosby, MS
Phone: 573-817-3275

Location Contact:

Columbia, Missouri 65212
United States

There is no listed contact information for this specific location.

Site Status: Recruiting

Data Source:

Date Processed: August 03, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.